Wells Fargo & Company Ark Genomic Revolution ETF (De Transaction History
Wells Fargo & Company
- $407 Billion
- Q2 2024
A detailed history of Wells Fargo & Company transactions in Ark Genomic Revolution ETF (De stock. As of the latest transaction made, Wells Fargo & Company holds 1,291,740 shares of ARKG stock, worth $32 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
1,291,740
Previous 1,303,299
0.89%
Holding current value
$32 Million
Previous $37.5 Million
19.08%
% of portfolio
0.01%
Previous 0.01%
Shares
18 transactions
Others Institutions Holding ARKG
# of Institutions
293Shares Held
21MCall Options Held
2.79MPut Options Held
6.56M-
Main Management ETF Advisors, LLC San Francisco, CA2.75MShares$68.3 Million3.23% of portfolio
-
Jpmorgan Chase & CO New York, NY2.26MShares$55.9 Million0.0% of portfolio
-
Ubs Group Ag1.75MShares$43.3 Million0.01% of portfolio
-
Morgan Stanley New York, NY1.54MShares$38.1 Million0.0% of portfolio
-
Bank Of America Corp Charlotte, NC1.46MShares$36.1 Million0.0% of portfolio